HST Global Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
SG&A Expense
157.30
149.00
160.00
137.30
153.00
142.60
EBIT
157.40
149.00
160.10
137.30
153.00
142.60
Unusual Expense
-
-
-
-
23.70
-
Interest Expense
35.40
35.70
35.70
35.70
35.70
35.70
Pretax Income
192.70
184.70
195.80
173.00
165.10
178.30
Consolidated Net Income
192.70
184.70
195.80
173.00
165.10
178.30
Net Income
192.70
184.70
195.80
173.00
165.10
178.30
Net Income After Extraordinaries
192.70
184.70
195.80
173.00
165.10
178.30
Net Income Available to Common
192.70
184.70
195.80
173.00
165.10
178.30
EPS (Basic)
0.01
0.00
0.01
0.00
0.00
-
Basic Shares Outstanding
36,719.90
36,719.90
36,719.90
36,719.90
36,719.90
36,719.90
EPS (Diluted)
0.01
0.01
0.01
0.00
0.00
-
Diluted Shares Outstanding
36,719.90
36,719.90
36,719.90
36,719.90
36,719.90
36,719.90
EBITDA
157.40
149.00
160.10
137.30
153.00
142.60

About HST Global

View Profile
Address
150 Research Drive
Hampton Virginia 23666
United States
Employees -
Website http://www.hstglobal.com
Updated 07/08/2019
HST Global, Inc. is a biotechnology and wellness company. The company discovers and develops breakthroughs in supporting and treating metabolic disorders associated with cancer and other life threatening illnesses. It develops and acquires a network of wellness centers, that are focused on the homeopathic and alternative treatment of stage cancer.